4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000950170-24-128609
CEO and President sold 2,505 shares at $0.54 ($1,355)
- CEO and President acquired 7,812 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Shaff Eric D. · CEO and President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,812 | 172,894 | D | ||
| 2024-11-18 | Sale : show line 2 in the form 10b5-1 | −2,505 | $0.54 | $1,355 | 170,389 | D |
| Open-market sales · 2,505 sh · avg $0.54 · $1,355 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-15 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −7,812 | 70,313 | D |
Loading xslF345X05/ownership.xml…